{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:03:58Z","timestamp":1790543038109,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic nephropathy (DN) is a common and serious complication of diabetes, characterized by chronic fibro-inflammatory processes with an unclear pathogenesis. Renal fibrosis plays a significant role in the development and progression of DN. While recent research suggests that the neddylation pathway may influence fibrotic processes, its specific dysregulation in DN and the underlying mechanisms remain largely unexplored. This study identified the neddylation of RhoA as a novel post-translational modification that regulates its expression and promotes renal fibrosis in DN. We here demonstrated that two key components of the neddylation pathway\u2014NEDD8-activating enzyme E1 subunit 1 (NAE1) and NEDD8\u2014are significantly upregulated in human chronic kidney disease (CKD) specimens compared to healthy kidneys, implicating neddylation in CKD-associated fibrosis. Our findings further revealed that both pharmacological inhibition of neddylation using MLN4924 and genetic knockdown of NAE1 mitigate renal fibrosis in mouse models of streptozotocin-induced diabetes and unilateral ureteral obstruction (UUO). Immunoprecipitation-mass spectrometry (IP-MS) and subsequent function assays demonstrated a direct interaction between RhoA and NEDD8. Importantly, neddylation inhibition reduced RhoA protein expression, highlighting a potential therapeutic target. Additionally, a positive correlation was noted between elevated NEDD8 mRNA levels and RhoA mRNA\u00a0expression in human CKD specimens. RhoA overexpression counteracted the antifibrotic effects of neddylation inhibition, underscoring its critical role in fibrosis progression. Mechanistically, we unveiled that neddylation enhances RhoA protein stability by inhibiting its ubiquitination-mediated degradation, which subsequently activates the ERK1\/2 pathway. Collectively, this study provides novel insights into NAE1-dependent RhoA neddylation as a key contributor to renal fibrosis in DN.<\/jats:p>","DOI":"10.1038\/s41401-024-01460-z","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T07:34:08Z","timestamp":1738568048000},"page":"1692-1705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy"],"prefix":"10.1038","volume":"46","author":[{"given":"Xue-qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-xian","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/ijms24010570","volume":"24","author":"K Watanabe","year":"2022","unstructured":"Watanabe K, Sato E, Mishima E, Miyazaki M, Tanaka T. What\u2019s new in the molecular mechanisms of diabetic kidney disease: recent advances. Int J Mol Sci. 2022;24:570.","journal-title":"Int J Mol Sci"},{"key":"1460_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248\u201360.","journal-title":"Kidney Int"},{"key":"1460_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","volume":"183","author":"L Wang","year":"2023","unstructured":"Wang L, Xu X, Zhang M, Hu C, Zhang X, Li C, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183:298\u2013310.","journal-title":"JAMA Intern Med"},{"key":"1460_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40620-017-0423-9","volume":"30","author":"L Zeni","year":"2017","unstructured":"Zeni L, Norden AGW, Cancarini G, Unwin RJ. A more tubulocentric view of diabetic kidney disease. J Nephrol. 2017;30:701\u201317.","journal-title":"J Nephrol"},{"key":"1460_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7:684\u201396.","journal-title":"Nat Rev Nephrol"},{"key":"1460_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108635","volume":"34","author":"S Lobato-Gil","year":"2021","unstructured":"Lobato-Gil S, Heidelberger JB, Maghames C, Bailly A, Brunello L, Rodriguez MS, et al. Proteome-wide identification of NEDD8 modification sites reveals distinct proteomes for canonical and atypical NEDDylation. Cell Rep. 2021;34:108635.","journal-title":"Cell Rep"},{"key":"1460_CR7","doi-asserted-by":"publisher","first-page":"28557","DOI":"10.1074\/jbc.272.45.28557","volume":"272","author":"T Kamitani","year":"1997","unstructured":"Kamitani T, Kito K, Nguyen HP, Yeh ET. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997;272:28557\u201362.","journal-title":"J Biol Chem"},{"key":"1460_CR8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1089\/ars.2013.5795","volume":"21","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Morgan MA, Sun Y. Targeting neddylation pathways to inactivate cullin-RING ligases for anticancer therapy. Antioxid Redox Signal. 2014;21:2383\u2013400.","journal-title":"Antioxid Redox Signal"},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm3919","volume":"16","author":"RI Enchev","year":"2015","unstructured":"Enchev RI, Schulman BA, Peter M. Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol. 2015;16:30\u201344.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1460_CR10","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1021\/acschembio.2c00099","volume":"17","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li M, Shen T, Yang T, Shi G, Wei Y, et al. Celastrol targets cullin-associated and neddylation-dissociated 1 to prevent fibroblast-myofibroblast transformation against pulmonary fibrosis. ACS Chem Biol. 2022;17:2734\u201343.","journal-title":"ACS Chem Biol"},{"key":"1460_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30559-2","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Lin W, Wang C, Sun F, Ju S, Chen Q, et al. Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3(SPOP) E3 ligase in cancer cells. Nat Commun. 2022;13:3034.","journal-title":"Nat Commun"},{"key":"1460_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jiang Y, Luo Q, Li L, Jia L. Neddylation: a novel modulator of the tumor microenvironment. Mol Cancer. 2019;18:77.","journal-title":"Mol Cancer"},{"key":"1460_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cellsig.2018.01.009","volume":"44","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhang W, Sun Y, Jia L. Protein neddylation and its alterations in human cancers for targeted therapy. Cell Signal. 2018;44:92\u2013102.","journal-title":"Cell Signal"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hep.28933","volume":"65","author":"I Zubiete-Franco","year":"2017","unstructured":"Zubiete-Franco I, Fernandez-Tussy P, Barbier-Torres L, Simon J, Fernandez-Ramos D, Lopitz-Otsoa F, et al. Deregulated neddylation in liver fibrosis. Hepatology. 2017;65:694\u2013709.","journal-title":"Hepatology"},{"key":"1460_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1139\/bcb-2021-0585","volume":"100","author":"W Zhou","year":"2022","unstructured":"Zhou W, Dong G, Gao G, He Z, Xu J, Aziz S, et al. Evaluation of HZX-960, a novel DCN1-UBC12 interaction inhibitor, as a potential antifibrotic compound for liver fibrosis. Biochem Cell Biol. 2022;100:309\u201324.","journal-title":"Biochem Cell Biol"},{"key":"1460_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yjmcc.2015.01.019","volume":"81","author":"D Pandey","year":"2015","unstructured":"Pandey D, Hori D, Kim JH, Bergman Y, Berkowitz DE, Romer LH. NEDDylation promotes endothelial dysfunction: a role for HDAC2. J Mol Cell Cardiol. 2015;81:18\u201322.","journal-title":"J Mol Cell Cardiol"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2023.05.011","volume":"35","author":"X Lu","year":"2023","unstructured":"Lu X, Kong X, Wu H, Hao J, Li S, Gu Z, et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metab. 2023;35:1390\u2013405:e8.","journal-title":"Cell Metab"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/pharmaceutics14112460","volume":"14","author":"M Ge","year":"2022","unstructured":"Ge M, Huang L, Ma Y, Sun S, Wu L, Xu W, et al. MLN4924 treatment diminishes excessive lipid storage in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) by stimulating hepatic mitochondrial fatty acid oxidation and lipid metabolites. Pharmaceutics. 2022;14:2460.","journal-title":"Pharmaceutics"},{"key":"1460_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01646-6","volume":"8","author":"H Peng","year":"2017","unstructured":"Peng H, Wang Q, Lou T, Qin J, Jung S, Shetty V, et al. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun. 2017;8:1493.","journal-title":"Nat Commun"},{"key":"1460_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101275","volume":"53","author":"M Serrano-Macia","year":"2021","unstructured":"Serrano-Macia M, Simon J, Gonzalez-Rellan MJ, Azkargorta M, Goikoetxea-Usandizaga N, Lopitz-Otsoa F, et al. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis. Mol Metab. 2021;53:101275.","journal-title":"Mol Metab"},{"key":"1460_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.850","volume":"12","author":"L Han","year":"2022","unstructured":"Han L, Zhang F, Liu Y, Yu J, Zhang Q, Ye X, et al. Uterus globulin associated protein 1 (UGRP1) binds podoplanin (PDPN) to promote a novel inflammation pathway during Streptococcus pneumoniae infection. Clin Transl Med. 2022;12:e850.","journal-title":"Clin Transl Med"},{"key":"1460_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/meth.2001.1266","volume":"25","author":"MS Rajeevan","year":"2001","unstructured":"Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods. 2001;25:443\u201351.","journal-title":"Methods"},{"key":"1460_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41422-020-00443-z","volume":"31","author":"P Xie","year":"2021","unstructured":"Xie P, Peng Z, Chen Y, Li H, Du M, Tan Y, et al. Neddylation of PTEN regulates its nuclear import and promotes tumor development. Cell Res. 2021;31:291\u2013311.","journal-title":"Cell Res"},{"key":"1460_CR24","first-page":"F180","volume":"269","author":"D Boivin","year":"1995","unstructured":"Boivin D, Beliveau R. Subcellular distribution and membrane association of Rho-related small GTP-binding proteins in kidney cortex. Am J Physiol. 1995;269:F180\u2013189.","journal-title":"Am J Physiol"},{"key":"1460_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mce.2013.01.007","volume":"369","author":"X Xie","year":"2013","unstructured":"Xie X, Peng J, Chang X, Huang K, Huang J, Wang S, et al. Activation of RhoA\/ROCK regulates NF-\u03baB signaling pathway in experimental diabetic nephropathy. Mol Cell Endocrinol. 2013;369:86\u201397.","journal-title":"Mol Cell Endocrinol"},{"key":"1460_CR26","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.bbamcr.2013.07.005","volume":"1833","author":"J Wei","year":"2013","unstructured":"Wei J, Mialki RK, Dong S, Khoo A, Mallampalli RK, Zhao Y, et al. A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2. Biochim Biophys Acta. 2013;1833:2757\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"1460_CR27","doi-asserted-by":"publisher","first-page":"C292","DOI":"10.1152\/ajpcell.00382.2021","volume":"324","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huang C, Duan ZB, Chen YX, Xu CY. LncRNA NEAT1 accelerates renal fibrosis progression via targeting miR-31 and modulating RhoA\/ROCK signal pathway. Am J Physiol Cell Physiol. 2023;324:C292\u2013C306.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1460_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/mol.115.097857","volume":"88","author":"OM Yu","year":"2015","unstructured":"Yu OM, Brown JH. G Protein-coupled receptor and RhoA-stimulated transcriptional responses: links to inflammation, differentiation, and cell proliferation. Mol Pharmacol. 2015;88:171\u201380.","journal-title":"Mol Pharmacol"},{"key":"1460_CR29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00018-018-2787-y","volume":"75","author":"E Nomikou","year":"2018","unstructured":"Nomikou E, Livitsanou M, Stournaras C, Kardassis D. Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases. Cell Mol Life Sci. 2018;75:2111\u201324.","journal-title":"Cell Mol Life Sci"},{"key":"1460_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jcm9051328","volume":"9","author":"TM Seccia","year":"2020","unstructured":"Seccia TM, Rigato M, Ravarotto V, Calo LA. ROCK (RhoA\/Rho Kinase) in cardiovascular-renal pathophysiology: a review of new advancements. J Clin Med. 2020;9:1328.","journal-title":"J Clin Med"},{"key":"1460_CR31","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1090772","volume":"302","author":"HR Wang","year":"2003","unstructured":"Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science. 2003;302:1775\u20139.","journal-title":"Science"},{"key":"1460_CR32","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00018-012-1170-7","volume":"70","author":"Y Cao","year":"2013","unstructured":"Cao Y, Zhang L. A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks. Cell Mol Life Sci. 2013;70:2305\u201317.","journal-title":"Cell Mol Life Sci"},{"key":"1460_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammaren HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:201.","journal-title":"Nat Commun"},{"key":"1460_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101083","volume":"86","author":"M Tang","year":"2022","unstructured":"Tang M, Kalim S. Avenues for post-translational protein modification prevention and therapy. Mol Asp Med. 2022;86:101083.","journal-title":"Mol Asp Med"},{"key":"1460_CR35","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/ndt\/gfv048","volume":"30","author":"PR Gajjala","year":"2015","unstructured":"Gajjala PR, Fliser D, Speer T, Jankowski V, Jankowski J. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Nephrol Dial Transpl. 2015;30:1814\u201324.","journal-title":"Nephrol Dial Transpl"},{"key":"1460_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.736006","volume":"9","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Chen Y, Wang G, Liu P, Xie G, Jing H, et al. Protein methylation in diabetic kidney disease. Front Med (Lausanne). 2022;9:736006.","journal-title":"Front Med (Lausanne)"},{"key":"1460_CR37","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1021\/acs.biochem.8b00567","volume":"57","author":"BC Jennings","year":"2018","unstructured":"Jennings BC, Lawton AJ, Rizk Z, Fierke CA. SmgGDS-607 regulation of RhoA GTPase prenylation is nucleotide-dependent. Biochemistry. 2018;57:4289\u201398.","journal-title":"Biochemistry"},{"key":"1460_CR38","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.2174\/156802611798281357","volume":"11","author":"F Ding","year":"2011","unstructured":"Ding F, Yin Z, Wang HR. Ubiquitination in Rho signaling. Curr Top Med Chem. 2011;11:2879\u201387.","journal-title":"Curr Top Med Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01460-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T06:32:21Z","timestamp":1747895541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01460-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01460-z","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}